Michael Jensen

Director, Ben Towne Center for Childhood Cancer, Seattle Children’s Research Institute

Renowned for his work in pediatric cancer research, Michael has served as the director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute since 2010. Prior to his tenure at the hospital, he conducted the first FDA authorized trial of T-cell therapies for children with recurrent neuroblastoma at City of Hope National Medical Center.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019